PCI asks state councils to issue registration to passed-out D.Pharm students of 2022-23 batch: Our Bureau, New Delhi ...

Cambridge, Massachusetts Wednesday, August 13, 2025, 15:00 Hrs [IST] ...

Cohance Lifesciences pumps in Rs. 230 mn to progress on its cGMP oligonucleotide unit at Hyderabad: Our Bureau, Bengaluru Wednesday, August 13, 2025, 14:15 Hrs [IST] Cohance Lifes ...

Indoco Remedies receives US FDA final approval for rivaroxaban tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg: Our Bureau, Mumbai Wednesday, August 13, 2025, 13:45 Hrs [IST] Indoco R ...

The 74th IPC’s official information brochure launched, signalling start of event's promotional and outreach activities: Our Bureau, Bengaluru Wednesday, August 13, 2025, 15:15 H ...

STEER World with its 200 kg/hr continuous granulation using patented INTEGRAAL system to accelerate pharm manufacturing: Our Bureau, Bengaluru Wednesday, August 13, 2025, 14:30 Hr ...

Abcentra begins patient dosing in phase 2b FORTIFY trial evaluating orticumab in patients with cardiovascular disease: Los Angeles Wednesday, August 13, 2025, 18:00 Hrs [IST] Abce ...

Our Bureau, Mumbai Wednesday, August 13, 2025, 17:20 Hrs [IST] Sino-international trade is accelerating as CPHI & PMEC China he ...

Anixa Biosciences’ chimeric antigen receptor-T cell technology receives US patent: San Jose, California Wednesday, August 13, 2025, 14:00 Hrs [IST] Anixa Biosciences, Inc. (Anix ...

Centrient Pharma joins UN Global Compact, reinforcing its commitment to ethical and sustainable growth: Our Bureau, Bengaluru Wednesday, August 13, 2025, 16:20 Hrs [IST] Centrient ...

Novartis announces positive results from VAYHIT2 phase III trial of ianalumab plus eltrombopag in patients with primary immune thrombocytopenia: Basel Wednesday, August 13, 2025, ...

Pfizer launches PCV20 for adults in India to offer broad protection against pneumococcal disease: Our Bureau, Mumbai Wednesday, August 13, 2025, 15:45 Hrs [IST] Pfizer has announc ...